Prudential Financial’s Tenaya Therapeutics TNYA Stock Holding History

Prudential Financial’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,200	Closed	-$11.5K	–	2515
2025 Q4	$11.5K	Buy	+16,200	New	+$22K	﹤0.01%	2205

Other funds holding TNYA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prudential Financial's TNYA Position: Q1 2026 in Review

Prudential Financial sold out of Tenaya Therapeutics (TNYA) in Q1 2026, closing a stake of 16,200 shares — an estimated $11.5K sold.

Prudential Financial first reported a position in TNYA in Q4 2025 and held it in 1 quarter. The position peaked at $11.5K in Q4 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

Prudential Financial reported no remaining Tenaya Therapeutics position as of Q1 2026 after selling out during the quarter.
Prudential Financial sold 16,200 Tenaya Therapeutics shares in Q1 2026, an estimated $11.5K.
Prudential Financial first reported a position in Tenaya Therapeutics in Q4 2025 and held it in 1 quarter.
Prudential Financial's Tenaya Therapeutics position peaked at $11.5K in Q4 2025.
103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.